Cohen Neil Harris bought CMMB
March 16, 2025 · Form 4 insider transaction
Cohen Neil Harris bought 3,821 shares of Chemomab Therapeutics Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 534 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,821
Price
$0.00
Total value
N/A
InsiderCohen Neil Harris
Role—
SecurityStock option (right to buy American Depositary Shares)
Transaction codeA: Grant or award
Transaction dateMarch 16, 2025
Filing dateSeptember 1, 2026
Shares owned after12,903
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options reported in this row were granted to the Reporting Person by the Issuer on March 16, 2025, and are fully vested and exercisable as of the date of this report.